Overview
CEF11, Epstein-Barr Virus BMLF1 (280-288) is an essential peptide for researchers studying the Epstein-Barr virus (EBV). This peptide represents a crucial HLA A2.1-restricted epitope derived from the EBV lytic protein BMLF1 (280-288). Its significance in immunological studies makes it a valuable tool for investigating viral infections and immune responses.
Key Features
- Derived from the Epstein-Barr virus lytic protein BMLF1
- HLA A2.1-restricted epitope, critical for immunological research
- High purity and quality suitable for various assays
- Supports research in viral immunology and therapeutic development
- Available in 1 mg unit size, perfect for laboratory use
Specifications
| Parameter | Detail |
|---|---|
| Catalog Number | CEF11 |
| Peptide Sequence | BMLF1 (280-288) |
| Unit Size | 1 mg |
| Purity | ≥95% |
FAQ
What is CEF11 used for?
CEF11 is primarily used in research focusing on Epstein-Barr virus immunology, helping to understand T-cell responses to EBV infections.
How should I store CEF11?
This peptide should be stored at -20°C for optimal stability and shelf life. Ensure it’s kept away from moisture and direct light.
Can CEF11 be used in vivo studies?
CEF11 is typically utilized in vitro for immunological assays rather than in vivo studies due to its specific nature. Always consult your lab protocols for appropriate applications.
For further peptide options, explore our extensive collection of peptides. Consider pairing CEF11 with other products like PKG Substrate RKRSRAE, Glasstide or Autocamtide-2 KKALRRQETVDAL to enhance your research outcomes.




Reviews
There are no reviews yet.